Lifecore Biomedical, Inc. \De\ (LFCR) Profit After Tax (2010 - 2025)

Lifecore Biomedical, Inc. \De\'s Profit After Tax history runs 16 years deep, the most recent figure standing at -$1.1 million for Q2 2025.

• In Q2 2025, Profit After Tax rose 83.81% year-over-year to -$1.1 million; the TTM figure through May 2025 stood at -$38.7 million (down 446.0% YoY), while the FY2025 annual figure was -$38.7 million, down 422.29% from the prior year.
• Profit After Tax for Q2 2025 stood at -$1.1 million, up from -$14.8 million in the prior quarter.
• The five-year high for Profit After Tax was $14.8 million in Q1 2024, with the low at -$38.5 million in Q4 2021.
• The 5-year median for Profit After Tax is -$9.3 million (2021), against an average of -$8.9 million.
• Peak annual rise in Profit After Tax reached 254.79% in 2023, while the deepest fall reached 919.23% in 2023.
• Lifecore Biomedical, Inc. \De\'s Profit After Tax stood at -$38.5 million in 2021, then jumped by 76.08% to -$9.2 million in 2022, then surged by 254.79% to $14.2 million in 2023, then sank by 146.14% to -$6.6 million in 2024, then surged by 82.54% to -$1.1 million in 2025.
• Business Quant data shows LFCR's Profit After Tax at -$1.1 million in Q2 2025, -$14.8 million in Q1 2025, and -$6.6 million in Q4 2024.